Heart problems can absolutely cause visual disturbances, and the range of ways they do so is wider than most people realize. A blood clot launched from the heart can blind an eye in seconds. Chronic poor blood flow from narrowed arteries can slowly dim vision over months. Heart failure, structural defects, aortic emergencies, and even common cardiac medications all have documented links to changes in what and how well you see. The connection runs deep enough that eye doctors sometimes detect heart disease before cardiologists do.
When a Clot Blocks the Eye’s Blood Supply
The most dramatic visual disturbance caused by a heart problem is a sudden blockage of the retinal artery, the vessel that feeds the light-sensing tissue at the back of your eye. Central retinal artery occlusion, or CRAO, is classified by the American Heart Association as a form of acute ischemic stroke, because the mechanism is the same: a clot or piece of debris travels through the bloodstream and lodges in a narrow artery, cutting off oxygen to the tissue downstream.1PubMed Central. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association The result is painless but alarming: sudden, severe vision loss in one eye, often described as a curtain dropping over the visual field.
Where does that clot come from? Frequently, the heart itself. Atrial fibrillation, damaged heart valves, and masses inside the heart chambers can all generate fragments that travel to the eye’s arteries. A population-based study found that people who experienced a CRAO faced roughly three times the risk of having a heart attack and nearly three times the risk of stroke compared to matched controls.2PubMed Central. Risk of cardiovascular events and death following retinal arterial occlusion and transient monocular visual loss That elevated risk tells you something important: a retinal artery blockage is not just an eye problem. It is a red flag that the cardiovascular system is generating dangerous clots.
A milder but equally telling version is transient monocular visual loss, historically called amaurosis fugax, Latin for “fleeting blindness.” Vision in one eye goes dark or gray for seconds to minutes, then returns to normal. The cause is usually a temporary interruption of blood flow to the retina from a small embolus or spasm.3PubMed Central. Transient Monocular Visual Loss (Amaurosis Fugax): How Does Age Impact Diagnosis? Because the vision recovers, people often dismiss the episode. That’s a mistake. It is frequently a warning that a larger, permanent blockage could follow.
Chronic Poor Blood Flow and Slowly Fading Vision
Not all heart-related visual disturbances come on suddenly. Ocular ischemic syndrome develops when the carotid arteries, the major vessels running up the neck to supply the head, become severely narrowed by plaque buildup. The eye sits at the end of that supply chain, so when flow drops far enough, the retina and other eye structures become chronically starved of oxygen. Symptoms creep in over weeks or months: dull aching eye pain, gradual vision loss, and sometimes the slow onset of abnormal blood vessel growth inside the eye.
The good news is that restoring blood flow through the carotid artery can help. A systematic review pooling data from 33 studies found that after procedures to reopen the carotid artery, vision either improved or at least held steady in more than 93% of patients. Worsening vision after the procedure was uncommon, occurring in only about 7% of cases, and was often related to the progression of disease elsewhere in the body rather than a failure of the procedure itself.4Annals of Vascular Surgery. Ocular Ischemic Syndrome and the Role of Carotid Artery Revascularization The takeaway is that the eye’s blood supply is part of the same vascular network feeding the brain, and anything that threatens that network threatens vision.
A Hole in the Heart and Visual Aura
One of the more surprising cardiac links to visual disturbance involves a patent foramen ovale, a small flap-like opening between the heart’s upper chambers that normally closes shortly after birth. In roughly a quarter of adults, it never fully seals. For most, this causes no problems. But research has turned up an unexpectedly strong connection between this structural defect and visual aura, the shimmering zigzag lines, blind spots, or scintillating patterns that some people experience, sometimes with migraine headaches and sometimes entirely on their own.
One study investigating non-migraine patients who had visual aura found that about two-thirds had a patent foramen ovale. After the opening was closed with a catheter-delivered device, roughly 80% of those patients saw improvement in their visual symptoms.5PubMed Central. The Correlation Between Migraine and Patent Foramen Ovale A separate study specifically examining patients who had visual aura without headache confirmed a higher prevalence of the defect among those patients and found that closing it correlated with improvement of the aura, suggesting a causative link rather than a coincidence.6PubMed Central. Visual migraine aura with or without headache: association with right to left shunt and assessment following transcutaneous closure
The suspected mechanism involves tiny clots or vasoactive substances that would normally be filtered by the lungs. When a patent foramen ovale allows blood to bypass the lungs by crossing directly between the atria, those substances can reach the brain’s visual cortex and trigger the aura phenomenon. Researchers found a similar pattern of right-to-left blood shunting across different patient groups, whether they experienced aura alone, aura with migraine, or typical migraine with aura, and closure of the defect improved symptoms in all groups.7PubMed. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache If you’ve been having unexplained visual aura episodes, especially without headache, this cardiac connection is worth knowing about.
Retinal Vein Occlusion as a Cardiovascular Warning
Sometimes the relationship runs in the other direction: an eye problem signals undiagnosed heart disease. Retinal vein occlusion, a blockage in the veins draining blood from the retina, causes sudden painless vision loss, blurriness, or dark spots. While the blockage itself happens in the eye, the underlying cause is almost always systemic vascular disease, particularly high blood pressure and atherosclerosis.
A cardiovascular risk assessment of patients with retinal vein occlusion found that their predicted 10-year risk of coronary heart disease was significantly higher than the general population. Among men with this eye condition, the proportion with a high predicted cardiac risk was roughly double what would be expected, and at the very highest risk threshold it was nearly six times higher. Women showed a similarly elevated pattern, with about four times as many falling into the high-risk category compared to population norms.8PubMed Central. Cardiovascular risk assessment in patients with retinal vein occlusion More recent research using carotid ultrasound has confirmed that retinal vein occlusion patients carry a heavy burden of silent atherosclerosis in their neck arteries, even when they have no symptoms of cardiovascular disease.9PubMed. Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles
The practical implication is that anyone diagnosed with retinal vein occlusion should get a thorough cardiovascular workup. The eye problem itself needs treatment, but it may be the first visible sign that arteries elsewhere in the body are in trouble.
Heart Failure and the Optic Nerve
Chronic heart failure affects the eye through a different route. When the heart cannot pump effectively, blood pressure drops, fluid balance shifts, and tissues throughout the body receive less oxygen. The optic nerve, which transmits visual information from the eye to the brain, is particularly sensitive to these changes because its blood supply comes from small end-arteries with little backup.
A study examining the optic nerve heads of patients with chronic heart failure found structural thinning that resembled changes seen in glaucoma. The degree of thinning correlated with how enlarged the heart’s left ventricle had become, a marker of more severe heart failure.10PubMed Central. Glaucomatous optic nerve head alterations in patients with chronic heart failure The worse the heart was functioning as a pump, the more the optic nerve tissue had wasted away. This raises the concern that long-standing heart failure may quietly damage vision through chronic underperfusion of the optic nerve, a process that could be mistaken for garden-variety glaucoma if the cardiac history isn’t considered.
Vision Loss After Heart Surgery
Heart surgery, while lifesaving, carries a small but real risk of postoperative vision loss. The most common culprit is ischemic optic neuropathy, damage to the optic nerve from insufficient blood flow during or after the operation. Factors like prolonged time on bypass, low blood pressure, blood loss, and swelling all contribute. A national database analysis identified certain cardiac procedures as particularly risky: left ventricular assist device implantation carried dramatically elevated odds of ischemic optic neuropathy, and coronary artery bypass grafting was also associated with increased risk.11PubMed Central. Ischemic Optic Neuropathy in Cardiac Surgery: Incidence and Risk Factors in the United States from the National Inpatient Sample 1998–2013
Case reports have documented patients waking from coronary bypass surgery with severe, bilateral vision loss from optic nerve damage.12PubMed Central. Two cases of bilateral ischemic optic neuropathy following coronary artery bypass grafting In some instances, elevated levels of homocysteine, an amino acid linked to vascular damage, may increase the risk of this complication.13PubMed Central. Hyperhomocysteinemia in bilateral anterior ischemic optic neuropathy after conventional coronary artery bypass graft The overall incidence remains low, but the stakes are high enough that it is one of the risks surgeons disclose before cardiac operations. If you’re scheduled for heart surgery, this is something to be aware of and to discuss with your surgical team, particularly if you have other risk factors for eye disease.
Aortic Dissection and Sudden Blindness
Aortic dissection, a tear in the wall of the body’s largest artery, is a well-known cardiovascular emergency typically recognized by tearing chest or back pain. What is less well known is that it can occasionally present with acute vision loss. A documented case described a patient whose aortic dissection caused sudden bilateral blindness along with loss of consciousness and chest pain.14Hong Kong Journal of Emergency Medicine. Transient binocular blindness: A rare presentation of aortic dissection The vision loss occurs because the dissection disrupts blood flow to the arteries supplying the eyes and brain. While this presentation is rare, it underscores a broader principle: any acute cardiovascular crisis that reduces blood flow to the head can affect vision. Sudden unexplained vision changes accompanied by chest pain, severe headache, or loss of consciousness should be treated as a medical emergency.
Cardiac Medications That Affect Vision
The medicines used to treat heart conditions can sometimes cause visual disturbances of their own, and these are easily confused with worsening heart disease if you don’t know what to look for.
Digoxin, one of the oldest heart medications still in use, is a well-known offender. Studies have found that close to 80% of patients taking digoxin developed some form of color vision change, even at doses considered therapeutic, though not all patients noticed or reported the disturbances. The classic presentation is a yellow or green tint to vision, but patients may also experience flashes of light, snowy or hazy vision, blind spots, and decreased sharpness.15PubMed Central. Colored floaters as a manifestation of digoxin toxicity The painter Vincent van Gogh has long been suspected of experiencing digoxin-related color shifts from foxglove-based medicines available in his era, though that remains speculation. What is not speculative is that anyone taking digoxin who notices a color shift or visual oddity should contact their doctor promptly, as it may signal that drug levels have risen too high.
Phosphodiesterase-5 inhibitors like sildenafil, widely used for erectile dysfunction and also prescribed for pulmonary hypertension, have been linked to ischemic optic neuropathy. The drug’s blood-vessel-dilating effects may reduce perfusion pressure to the optic nerve head, particularly in people whose anatomy makes them vulnerable.16PubMed Central. Sildenafil-Associated Anterior Ischemic Optic Neuropathy with Optic Nerve Enhancement in Brain Magnetic Resonance Imaging and Pleocytosis in Cerebrospinal Fluid The risk is small but real, and it’s compounded by the fact that the same vascular risk factors that lead people to cardiac medications in the first place, like high blood pressure and diabetes, also make the optic nerve more susceptible to reduced blood flow.
Cardiac Tumors and Rare Embolic Sources
Among the rarer causes of heart-related vision loss are cardiac tumors, the most common being a myxoma, a benign growth typically found in the left atrium. Myxomas can shed fragments into the bloodstream, and when those fragments travel to the retinal artery, the result is sudden blindness. This occurs primarily in older adults, though case reports have documented it in pediatric patients as well.17PubMed Central. Acute blindness as a presenting sign of left atrial myxoma in a pediatric patient In some cases, the vision loss is the very first sign that a tumor exists in the heart. These events are rare enough that most eye doctors may see only a handful in a career, but they illustrate how an unexpected visual disturbance can be the canary in the coal mine for a serious cardiac condition.
Cyanotic Heart Disease and Thick Blood
Congenital heart defects that cause cyanosis, the bluish discoloration of skin from low oxygen levels, create a distinct pathway to visual problems. When blood oxygen is chronically low, the body compensates by producing more red blood cells. The resulting thickening of the blood, sometimes called hyperviscosity, slows flow through the smallest blood vessels, including those in the eye. Symptoms of hyperviscosity include headache, fatigue, tingling sensations, and loss of vision.18PubMed Central. Hyperviscosity syndrome revisited The vision loss in these cases results from sluggish or stalled blood flow in the retinal microcirculation. This is particularly relevant for adults living with uncorrected or partially corrected congenital heart defects, a population that is growing as surgical survival improves.
Fainting, Near-Fainting, and Graying Vision
Not every heart-related visual disturbance involves blocked arteries or structural damage. One of the most common is the graying or tunneling of vision that happens when blood pressure drops suddenly, the kind of thing you might experience when standing up too fast or during a vasovagal episode triggered by pain, heat, or prolonged standing. The visual dimming is caused by a temporary drop in blood flow to the brain, and it’s the same mechanism behind fainting: insufficient perfusion to keep neural tissues working properly. For most people this is benign and fleeting. But if episodes are frequent, prolonged, or accompanied by loss of consciousness, they can indicate an underlying cardiac rhythm problem, structural heart issue, or autonomic nervous system disorder that deserves investigation.
Your Eyes as a Window Into Heart Health
The retina is the only place in the body where doctors can directly observe blood vessels without surgery. That unique access has turned the eye into a cardiovascular screening tool. Changes in the retina’s tiny arteries and veins, including narrowing, thickening of vessel walls, tiny hemorrhages, and micro-aneurysms, have been consistently linked to cardiovascular and cerebrovascular disease, independent of traditional risk factors like cholesterol or blood pressure readings.19Acta Ophthalmologica. Retinal microvascular signs as biomarkers of cardiovascular disease
Artificial intelligence is pushing this further. Researchers have trained algorithms to predict future cardiovascular events by analyzing optical coherence tomography scans, detailed cross-sectional images of the retina. One model achieved about 70% accuracy in predicting who would go on to develop cardiovascular disease, with the choroidal layer, the blood-vessel-rich tissue beneath the retina, emerging as a key indicator.20PubMed Central. Predicting cardiovascular disease risk using retinal optical coherence tomography imaging The technology is still in its early stages, but it points toward a future where a routine eye exam could flag heart disease risk years before symptoms appear. For now, the clinical reality is simpler but still valuable: if your eye doctor notices vascular changes in the retina during a standard exam, it is worth following up with your primary care doctor or a cardiologist to check what’s happening in the rest of your circulatory system.